Abstract
Objectives Bone age (BA) assessment is important in evaluating disorders of growth and puberty; the Greulich and Pyle atlas method (GP) is most used. We aimed to determine the weightage to be attributed by raters to various segments of the hand x-ray, namely, distal end of radius-ulna (RU), carpals, and short bones for rating bone age using the GP atlas method.
Methods 692 deidentified x-rays from a previous study (PUNE-dataset) and 400 from the Radiological Society of North America (RSNA-dataset) were included in the study. Mean of BA assessed by experienced raters was termed reference rating. Linear regression was used to model reference age as function of age ratings of the three segments. The root-mean-square-error (RMSE) of segmental arithmetic mean and weighted mean with respect to reference rating were computed for both datasets.
Results Short bones were assigned the highest weightage. Carpals were assigned higher weightage in pre-pubertal PUNE participants as compared to RSNA, vice-versa in RU segment of post-pubertal participants. The RMSE of weighted mean ratings was significantly lower than for the arithmetic mean in the PUNE dataset.
Conclusion We thus determined weightage to be attributed by raters to segments of the hand x-ray for assessment of bone age by the GP method.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The project was funded by grants from the Department of Biotechnology (no- BT/PR41073/Swdn/135/4/2020) and Vinnova (no 2020-03609)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The original study (PUNE) was approved by the institutional ethics committee and all participants gave written informed consent (original approval was dated 7 Aug 2019). Since we used deidentified data, a waiver was granted by the ethics committee (approval dated 9 July 2020). This study was approved by the Ethics Committee of the Indian Institute of Science Education and Research Pune (IHEC/Admin/2021/014).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Declarations: No declarations
Research funding: The project was funded by grants from the Department of Biotechnology (no-BT/PR41073/Swdn/135/4/2020) and Vinnova (no 2020-03609)
Competing interest: The authors have no relevant financial or non-financial interests to disclose.
Compliance with ethical standards: Yes
Consent to participate: Informed consent was obtained from all individual participants included in the original study.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
